Fitodenta - Company finances
|
EUR
|
2020
From: 2020-02-10
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|
|
Financial data
|
||||||
| Sales revenue | - | - | - | 2,793 | 6,023 | 16,651 |
| Profit before tax | - | - | - | - | -138,661 | -147,532 |
| Net profit | -1,663 | -9,852 | -58,251 | -137,125 | -138,661 | -147,532 |
| Equity | 1,777 | 94,924 | 141,673 | 109,548 | -29,113 | 36,650 |
| Liabilities | 4,698 | 4,373 | 7,530 | 7,044 | 81,215 | 63,491 |
| Non-current assets | 0 | 82,680 | 76,245 | 50,040 | 11,026 | 3,046 |
| Current assets | 30,011 | 83,342 | 105,389 | 84,138 | 31,859 | 83,966 |
| Total assets | 30,011 | 166,022 | 181,634 | 134,178 | 42,885 | 87,012 |
|
Taxes paid
|
||||||
| STI taxes | - | - | - | - | - | 9,096 |
| Social insurance contributions | - | - | - | 4,584 | 14,191 | 16,330 |
|
Financial indicators
|
||||||
| Revenue change y/y | - | - | - | - | +115.6% | +176.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -5.5% | -5.9% | -32.1% | -102.2% | -323.3% | -169.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -93.6% | -10.4% | -41.1% | -125.2% | - | -402.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | -4909.6% | -2302.2% | -886.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | -2302.2% | -886.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.6 | 0.0 | 0.1 | 0.1 | - | 1.7 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | 986 | 1,506 | 4,163 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Fitodenta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2024-11-18 | 2024-11-20 | 0.07 |
| 2024-10-24 | 2024-11-04 | 0.07 |
Fitodenta - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-04-04 | 2025-04-04 | 1143.83 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Fitodenta, UAB (company code 305460265) is a private limited liability company active in research and development in medical sciences. In the latest financial year, 2025, revenue increased to €16.7K from €6.0K in 2024 and €2.8K in 2023, indicating a strong upward trend in turnover over two years. Despite this growth, the company remained loss-making, posting a net loss of €147.5K in 2025 after losses of €138.7K in 2024 and €137.1K in 2023. With revenue still at a very small level, profitability ratios are affected by the limited base, but the business continued to generate a substantial operating loss. At the end of 2025, total assets stood at €87.0K, equity at €36.6K and liabilities at €63.5K. The position improved from 2024, when equity was negative at -€29.1K and total assets were €42.9K. For 2025, ROE was -402.5%, ROA -169.6%, debt-to-equity 1.73 and asset turnover 0.19x. Revenue per employee was €4.2K and profit per employee was -€36.9K.